PFIZER INC — Director's Dealing 2020

Feb 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-26

Reporting Person: Hwang Angela (Group President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-26	Common Stock	M	14493.0000	$34.5900	Acquired	32470.0000	Direct
2020-02-26	Common Stock	F	1166.0000	$34.7200	Disposed	31304.0000	Direct
2020-02-26	Common Stock	F	11063.0000	$36.8000	Disposed	20241.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-26	Phantom Stock Units	$	A	3164.0000	Acquired		Common Stock (3164.0000)	Direct
2020-02-26	Stock Appreciation Rights	$34.5900	M	14493.0000	Disposed	2020-02-26	Common Stock (14493.0000)	Direct
2020-02-27	Stock Appreciation Rights	$34.1000	A	170368.0000	Acquired	2025-02-27	Common Stock (170368.0000)	Direct
2020-02-27	Stock Appreciation Rights	$34.1000	A	145969.0000	Acquired	2027-02-27	Common Stock (145969.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13338.0000	Indirect
Common Stock	8532.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F5: The reporting person disclaims beneficial ownership of the shares held by spouse.

F6: Each unit represents one phantom share of common stock.

F7: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan.

F8: The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F9: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F10: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.